Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Severe disseminated tuberculosis in HIV-negative refugees.

Suárez I, Maria Fünger S, Jung N, Lehmann C, Reimer RP, Mehrkens D, Bunte A, Plum G, Jaspers N, Schmidt M, Fätkenheuer G, Rybniker J.

Lancet Infect Dis. 2019 Jun 7. pii: S1473-3099(19)30162-8. doi: 10.1016/S1473-3099(19)30162-8. [Epub ahead of print] Review.

PMID:
31182290
2.

Mould-reactive T cells for the diagnosis of invasive mould infection-A prospective study.

Steinbach A, Cornely OA, Wisplinghoff H, Schauss AC, Vehreschild JJ, Rybniker J, Hamprecht A, Richter A, Bacher P, Scheffold A, Koehler P.

Mycoses. 2019 Jul;62(7):562-569. doi: 10.1111/myc.12919. Epub 2019 May 23.

PMID:
31034691
3.

Synthesis of New Cyclomarin Derivatives and Their Biological Evaluation towards Mycobacterium Tuberculosis and Plasmodium Falciparum.

Kiefer A, Bader CD, Held J, Esser A, Rybniker J, Empting M, Müller R, Kazmaier U.

Chemistry. 2019 Apr 23. doi: 10.1002/chem.201901640. [Epub ahead of print]

PMID:
31012978
4.

Diagnostic challenges in infective endocarditis: is PET/CT the solution?

Hohmann C, Michels G, Schmidt M, Pfister R, Mader N, Ohler M, Blanke L, Jazmati N, Lehmann C, Rybniker J, Fünger SM, Fätkenheuer G, Jung N.

Infection. 2019 Feb 13. doi: 10.1007/s15010-019-01278-6. [Epub ahead of print]

PMID:
30847769
5.

Corticosteroids inhibit Mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition.

Gräb J, Suárez I, van Gumpel E, Winter S, Schreiber F, Esser A, Hölscher C, Fritsch M, Herb M, Schramm M, Wachsmuth L, Pallasch C, Pasparakis M, Kashkar H, Rybniker J.

Nat Commun. 2019 Feb 8;10(1):688. doi: 10.1038/s41467-019-08405-9.

6.

Combination Antimicrobial Therapy for Enterococcus faecalis Infective Endocarditis.

Koehler P, Jung N, Cornely OA, Rybniker J, Fätkenheuer G.

Clin Infect Dis. 2019 Feb 1. doi: 10.1093/cid/ciz054. [Epub ahead of print] No abstract available.

PMID:
30715308
7.

HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?

Drößler L, Lehmann C, Töpelt K, Nierhoff D, Vehreschild JJ, Rybniker J, Hallek M, Fischer J, Stormberg V, Fätkenheuer G, Wieland U, Jung N.

Infection. 2019 Apr;47(2):293-300. doi: 10.1007/s15010-019-01271-z. Epub 2019 Jan 28.

PMID:
30689161
8.

No Evidence for Acquired Mutations Associated with Cytochrome bc 1 Inhibitor Resistance in 13,559 Clinical Mycobacterium tuberculosis Complex Isolates.

Rybniker J, Kohl TA, Barilar I, Niemann S.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01317-18. doi: 10.1128/AAC.01317-18. Print 2019 Jan. No abstract available.

9.

Postoperative granulomatous peritonitis mimicking abdominal tuberculosis.

Kasper P, Pütz K, Fünger S, Suárez I, Jung N, Alakus H, Bruns C, Rybniker J.

Clin Case Rep. 2018 Jul 25;6(9):1810-1814. doi: 10.1002/ccr3.1724. eCollection 2018 Sep.

10.

Short Communication: Tracking Tregs: Translocation of CD49b/LAG-3+ Type 1 T Regulatory Cells to the Gut-Associated Lymphoid Tissue of HIV+ Patients.

Augustin M, Horn C, Koch J, Sandaradura de Silva U, Platten M, Nierhoff D, Suarez I, Chon SH, Rybniker J, Lehmann C.

AIDS Res Hum Retroviruses. 2019 Mar;35(3):247-250. doi: 10.1089/AID.2018.0052. Epub 2018 Sep 11.

PMID:
30019612
11.

To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.

Scholten M, Suárez I, Platten M, Kümmerle T, Jung N, Wyen C, Ernst A, Horn C, Burst V, Suárez V, Rybniker J, Fätkenheuer G, Lehmann C.

HIV Med. 2018 Oct;19(9):645-653. doi: 10.1111/hiv.12645. Epub 2018 Jul 11.

PMID:
29993176
12.

Case Report: A Cryptosporidium infection in a patient with relapsed T-lymphoblastic lymphoma undergoing allogeneic stem cell transplantation.

Schiller J, Klein S, Engels M, Büttner R, Rybniker J, Fätkenheuer G, Scheid C, Wybranski C, Quaas A, Reinhardt HC, Flümann R.

Eur J Haematol. 2018 Apr;100(4):383-385. doi: 10.1111/ejh.12998. Epub 2017 Dec 17.

PMID:
29140544
13.

Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.

Suárez I, Lehmann C, Gruell H, Graeb J, Kochanek M, Fätkenheuer G, Plum G, van Wengen A, van de Vosse E, Hartmann P, Hanitsch LG, Rybniker J.

Clin Infect Dis. 2017 Aug 1;65(3):518-521. doi: 10.1093/cid/cix372.

PMID:
28430999
14.

Novel and revisited approaches in antituberculosis drug discovery.

Herrmann J, Rybniker J, Müller R.

Curr Opin Biotechnol. 2017 Dec;48:94-101. doi: 10.1016/j.copbio.2017.03.023. Epub 2017 Apr 17. Review.

PMID:
28427007
15.

Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort.

Suárez I, Roderus L, van Gumpel E, Jung N, Lehmann C, Fätkenheuer G, Hartmann P, Plum G, Rybniker J.

Infection. 2017 Jun;45(3):341-347. doi: 10.1007/s15010-017-1005-4. Epub 2017 Mar 16.

PMID:
28303545
16.

EspC forms a filamentous structure in the cell envelope of Mycobacterium tuberculosis and impacts ESX-1 secretion.

Lou Y, Rybniker J, Sala C, Cole ST.

Mol Microbiol. 2017 Jan;103(1):26-38. doi: 10.1111/mmi.13575. Epub 2016 Nov 25.

17.

Familial acquired thrombotic thrombocytopenic purpura in siblings - no immunogenetic link with associated human leucocyte antigens.

Gödel P, Fischer J, Scheid C, Gathof BS, Wolf J, Rybniker J.

Eur J Haematol. 2017 Mar;98(3):311-313. doi: 10.1111/ejh.12831. Epub 2016 Dec 7.

PMID:
27859681
18.

Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria.

Singh V, Dhar N, Pató J, Kolly GS, Korduláková J, Forbak M, Evans JC, Székely R, Rybniker J, Palčeková Z, Zemanová J, Santi I, Signorino-Gelo F, Rodrigues L, Vocat A, Covarrubias AS, Rengifo MG, Johnsson K, Mowbray S, Buechler J, Delorme V, Brodin P, Knott GW, Aínsa JA, Warner DF, Kéri G, Mikušová K, McKinney JD, Cole ST, Mizrahi V, Hartkoorn RC.

Mol Microbiol. 2017 Jan;103(1):13-25. doi: 10.1111/mmi.13535. Epub 2016 Oct 29.

19.

Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.

Foo CS, Lechartier B, Kolly GS, Boy-Röttger S, Neres J, Rybniker J, Lupien A, Sala C, Piton J, Cole ST.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6451-6459. doi: 10.1128/AAC.01523-16. Print 2016 Nov.

20.

Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.

Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, Robins JM, Abgrall S, Shepherd BE, Deeks SG, John Gill M, Touloumi G, Vourli G, Dabis F, Vandenhende MA, Reiss P, van Sighem A, Samji H, Hogg RS, Rybniker J, Sabin CA, Jose S, Del Amo J, Moreno S, Rodríguez B, Cozzi-Lepri A, Boswell SL, Stephan C, Pérez-Hoyos S, Jarrin I, Guest JL, D'Arminio Monforte A, Antinori A, Moore R, Campbell CN, Casabona J, Meyer L, Seng R, Phillips AN, Bucher HC, Egger M, Mugavero MJ, Haubrich R, Geng EH, Olson A, Eron JJ, Napravnik S, Kitahata MM, Van Rompaey SE, Teira R, Justice AC, Tate JP, Costagliola D, Sterne JA, Hernán MA; Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Network of Integrated Clinical Systems, and the HIV-CAUSAL Collaboration.

Int J Epidemiol. 2016 Dec 1;45(6):2038-2049. doi: 10.1093/ije/dyv295.

21.

Lansoprazole is an antituberculous prodrug targeting cytochrome bc1.

Rybniker J, Vocat A, Sala C, Busso P, Pojer F, Benjak A, Cole ST.

Nat Commun. 2015 Jul 9;6:7659. doi: 10.1038/ncomms8659.

22.

Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1.

Wassermann R, Gulen MF, Sala C, Perin SG, Lou Y, Rybniker J, Schmid-Burgk JL, Schmidt T, Hornung V, Cole ST, Ablasser A.

Cell Host Microbe. 2015 Jun 10;17(6):799-810. doi: 10.1016/j.chom.2015.05.003. Epub 2015 Jun 2.

23.

Anticytolytic screen identifies inhibitors of mycobacterial virulence protein secretion.

Rybniker J, Chen JM, Sala C, Hartkoorn RC, Vocat A, Benjak A, Boy-Röttger S, Zhang M, Székely R, Greff Z, Orfi L, Szabadkai I, Pató J, Kéri G, Cole ST.

Cell Host Microbe. 2014 Oct 8;16(4):538-48. doi: 10.1016/j.chom.2014.09.008.

24.

EspI regulates the ESX-1 secretion system in response to ATP levels in Mycobacterium tuberculosis.

Zhang M, Chen JM, Sala C, Rybniker J, Dhar N, Cole ST.

Mol Microbiol. 2014 Sep;93(5):1057-1065. doi: 10.1111/mmi.12718. Epub 2014 Jul 31.

25.

The cysteine desulfurase IscS of Mycobacterium tuberculosis is involved in iron-sulfur cluster biogenesis and oxidative stress defence.

Rybniker J, Pojer F, Marienhagen J, Kolly GS, Chen JM, van Gumpel E, Hartmann P, Cole ST.

Biochem J. 2014 May 1;459(3):467-78. doi: 10.1042/BJ20130732.

PMID:
24548275
26.

Tuberculosis drug discovery in the post-post-genomic era.

Lechartier B, Rybniker J, Zumla A, Cole ST.

EMBO Mol Med. 2014 Feb;6(2):158-68. doi: 10.1002/emmm.201201772. Epub 2014 Jan 8. Review.

27.

Phenotypic profiling of Mycobacterium tuberculosis EspA point mutants reveals that blockage of ESAT-6 and CFP-10 secretion in vitro does not always correlate with attenuation of virulence.

Chen JM, Zhang M, Rybniker J, Basterra L, Dhar N, Tischler AD, Pojer F, Cole ST.

J Bacteriol. 2013 Dec;195(24):5421-30. doi: 10.1128/JB.00967-13. Epub 2013 Sep 27.

28.

Mycobacterium tuberculosis EspB binds phospholipids and mediates EsxA-independent virulence.

Chen JM, Zhang M, Rybniker J, Boy-Röttger S, Dhar N, Pojer F, Cole ST.

Mol Microbiol. 2013 Sep;89(6):1154-66. doi: 10.1111/mmi.12336. Epub 2013 Aug 15.

29.

Incorporation of antigens into viral capsids augments immunogenicity of adeno-associated virus vector-based vaccines.

Rybniker J, Nowag A, Janicki H, Demant K, Hartmann P, Büning H.

J Virol. 2012 Dec;86(24):13800-4. doi: 10.1128/JVI.01708-12. Epub 2012 Oct 3.

30.

The cytotoxic early protein 77 of mycobacteriophage L5 interacts with MSMEG_3532, an L-serine dehydratase of Mycobacterium smegmatis.

Rybniker J, Krumbach K, van Gumpel E, Plum G, Eggeling L, Hartmann P.

J Basic Microbiol. 2011 Oct;51(5):515-22. doi: 10.1002/jobm.201000446. Epub 2011 Jun 9.

PMID:
21656815
31.

Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection.

Shimabukuro-Vornhagen A, Rybniker J, Zoghi S, Faetkenheuer G, Michels G, Erdmann E, von Bergwelt-Baildon M, Kochanek M.

Case Rep Med. 2010;2010. pii: 278427. doi: 10.1155/2010/278427. Epub 2010 Aug 23.

32.

Insights into the function of the WhiB-like protein of mycobacteriophage TM4--a transcriptional inhibitor of WhiB2.

Rybniker J, Nowag A, van Gumpel E, Nissen N, Robinson N, Plum G, Hartmann P.

Mol Microbiol. 2010 Aug;77(3):642-57. doi: 10.1111/j.1365-2958.2010.07235.x. Epub 2010 Jun 9.

33.

Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.

Rybniker J, Goede V, Mertens J, Ortmann M, Kulas W, Kochanek M, Benzing T, Arribas JR, Fätkenheuer G.

Int J Infect Dis. 2010 Jun;14(6):e522-5. doi: 10.1016/j.ijid.2009.06.010. Epub 2009 Sep 1. Review.

34.

Orientia tsutsugamushi bacteremia and cytokine levels in Vietnamese scrub typhus patients.

Kramme S, An le V, Khoa ND, Trin le V, Tannich E, Rybniker J, Fleischer B, Drosten C, Panning M.

J Clin Microbiol. 2009 Mar;47(3):586-9. doi: 10.1128/JCM.00997-08. Epub 2009 Jan 14.

35.

Mycobacterial phenolic glycolipid inhibits phagosome maturation and subverts the pro-inflammatory cytokine response.

Robinson N, Kolter T, Wolke M, Rybniker J, Hartmann P, Plum G.

Traffic. 2008 Nov;9(11):1936-47. doi: 10.1111/j.1600-0854.2008.00804.x. Epub 2008 Aug 7.

36.

Identification of three cytotoxic early proteins of mycobacteriophage L5 leading to growth inhibition in Mycobacterium smegmatis.

Rybniker J, Plum G, Robinson N, Small PL, Hartmann P.

Microbiology. 2008 Aug;154(Pt 8):2304-14. doi: 10.1099/mic.0.2008/017004-0.

PMID:
18667563
38.

Supplemental Content

Loading ...
Support Center